Leave feedback

2-({1-[3-(1H-1,2,3,4-tetrazol-1-yl)benzoyl]azetidin-3-yl}oxy)-1,3-benzothiazole



Compound number:
MolPort-030-070-094
CAS number: 1795194-33-0
IUPAC:
2-({1-[3-(1H-1,2,3,4-tetrazol-1-yl)benzoyl]azetidin-3-yl}oxy)-1,3-benzothiazole
IUPAC traditional:
2-({1-[3-(1,2,3,4-tetrazol-1-yl)benzoyl]azetidin-3-yl}oxy)-1,3-benzothiazole
SMILES:
O=C(N1CC(C1)Oc1nc2ccccc2s1)c1cccc(c1)-n1cnnn1
InChI key:
FUYZVRRRTBKGEI-UHFFFAOYSA-N
Molecular formula:
C18H14N6O2S
Molecular weight: 378.41
Solubility: not available

Marketplace Offers

Direct S&H to USA: 130.00 USD
Direct S&H to World: 150.00 USD

During check-out process you will be able to choose between:
  - Consolidated MolPort Shipping
  - Direct Shipping

Supplier Catalogue Data


Catalog: Screening compound Ships out: 10 business days Purity: >90%
Last updated: today In warehouse: 132.70 mg
Pack size Ships out Price Qty
1 mg July 2, 2021 54.00 USD
ADD TO CART
2 mg July 2, 2021 59.00 USD
ADD TO CART
3 mg July 2, 2021 63.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-030-070-094
CAS number: 1795194-33-0

Names, Synonyms and 3rd Party Identifiers

InChI
InChI: 1S/C18H14N6O2S/c25-17(12-4-3-5-13(8-12)24-11-19-21-22-24)23-9-14(10-23)26-18-20-15-6-1-2-7-16(15)27-18/h1-8,11,14H,9-10H2
InChI key: FUYZVRRRTBKGEI-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C18H14N6O2S
Molecular weight: 378.41

Other

Sales contact

+1 (215) 9991090

+371 67881775

sales@molport.com


At MolPort, we welcome your thoughts, comments, questions and feedback. Our customer services department will be happy to help you Monday to Friday 7 a.m. to 4 p.m. GMT (2 a.m. - 10 a.m. EST).
Exceptions - closed on national holidays in Latvia (headquarters).


2021 MolPort, v4.78, release date 16-06-2021 23:30 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.